34.90
Schlusskurs vom Vortag:
$35.77
Offen:
$35.99
24-Stunden-Volumen:
3.60M
Relative Volume:
0.90
Marktkapitalisierung:
$15.09B
Einnahmen:
$2.31B
Nettoeinkommen (Verlust:
$1.66B
KGV:
15.17
EPS:
2.3
Netto-Cashflow:
$827.02M
1W Leistung:
-2.32%
1M Leistung:
-3.03%
6M Leistung:
+3.38%
1J Leistung:
+26.22%
Royalty Pharma Plc Stock (RPRX) Company Profile
Firmenname
Royalty Pharma Plc
Sektor
Branche
Telefon
(212) 883-0200
Adresse
110 EAST 59TH STREET, NEW YORK, NY
Vergleichen Sie RPRX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
RPRX
Royalty Pharma Plc
|
34.90 | 15.46B | 2.31B | 1.66B | 827.02M | 2.30 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-05-16 | Eingeleitet | Morgan Stanley | Overweight |
2024-06-03 | Herabstufung | UBS | Buy → Neutral |
2022-06-14 | Fortgesetzt | UBS | Buy |
2022-05-13 | Eingeleitet | Scotiabank | Sector Outperform |
2022-04-27 | Eingeleitet | Goldman | Buy |
2022-04-14 | Hochstufung | JP Morgan | Neutral → Overweight |
2022-04-06 | Fortgesetzt | Morgan Stanley | Overweight |
2021-10-29 | Hochstufung | Citigroup | Neutral → Buy |
2021-07-30 | Eingeleitet | Tigress Financial | Buy |
2020-11-09 | Hochstufung | UBS | Neutral → Buy |
2020-07-14 | Eingeleitet | Evercore ISI | In-line |
2020-07-13 | Eingeleitet | BofA Securities | Buy |
2020-07-13 | Eingeleitet | Citigroup | Neutral |
2020-07-13 | Eingeleitet | Cowen | Outperform |
2020-07-13 | Eingeleitet | Goldman | Neutral |
2020-07-13 | Eingeleitet | JP Morgan | Neutral |
2020-07-13 | Eingeleitet | Morgan Stanley | Equal-Weight |
2020-07-13 | Eingeleitet | SunTrust | Buy |
2020-07-13 | Eingeleitet | UBS | Neutral |
Alle ansehen
Royalty Pharma Plc Aktie (RPRX) Neueste Nachrichten
Ruffer LLP Makes New $6.41 Million Investment in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma plc (RPRX) Completes $2B Senior Notes Offering, Strengthens Capital for Growth - Insider Monkey
Wedge Capital Management L L P NC Grows Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma at Bernstein Forum: Strategic Insights on Growth By Investing.com - Investing.com UK
Transcript : Royalty Pharma plc Presents at Bernstein Insights - MarketScreener
Mn Services Vermogensbeheer B.V. Acquires Shares of 67,000 Royalty Pharma PLC $RPRX - MarketBeat
Why Royalty Pharma (RPRX) is the Cheapest Stock to Buy on Robinhood? - MSN
Ridgewood Investments LLC Sells 11,236 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Strs Ohio Invests $1.89 Million in Royalty Pharma PLC $RPRX - MarketBeat
Pacific Capital Partners Ltd Sells 77,500 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Sell Signal: Does HAIN align with a passive investing strategyPortfolio Gains Report & Fast Momentum Entry Tips - khodrobank.com
Analyst Downgrade: Why is Royalty Pharma plc stock going downJuly 2025 Trends & AI Enhanced Trading Alerts - khodrobank.com
Here's How Much $1000 Invested In Royalty Pharma 15 Years Ago Would Be Worth Today - Sahm
Understanding Royalty Pharma plc’s price movementJuly 2025 Trends & Short-Term Swing Trade Alerts - newser.com
Royalty Pharma to Present at Bernstein’s 2nd Annual Healthcare Forum - The Manila Times
Leading Biopharma Royalty Investor Royalty Pharma Featured at Bernstein Healthcare Forum 2025 - Stock Titan
Layoff Watch: Will Royalty Pharma plc benefit from rate cutsWeekly Trend Recap & Stock Market Timing Techniques - khodrobank.com
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Buys 226,048 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Market Outlook: Should I buy Royalty Pharma plc stock now2025 Market Overview & Daily Entry Point Alerts - خودرو بانک
Royalty Pharma (NASDAQ:RPRX) Downgraded to Hold Rating by Wall Street Zen - MarketBeat
Nasdaq Moves: What are the analyst revisions for GCLWWIs Royalty Pharma plc stock a good investment in YEARJuly 2025 Macro Moves & Verified Chart Pattern Trade Signals - خودرو بانک
Royalty Pharma’s $2 Billion Debt Offering Could Be a Game Changer for RPRX - simplywall.st
TD Cowen Maintains a Buy on Royalty Pharma (RPRX) - Insider Monkey
Royalty Pharma Plc Experiences Evaluation Revision Amidst Market Dynamics and Performance Variability - Markets Mojo
Syndax, Royalty Pharma enter into $350M royalty funding deal - MSN
12 Affordable Biotech Stocks to Invest In Now - Insider Monkey
Empowered Funds LLC Buys New Shares in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma Completes $2 Billion Senior Notes Offering - TipRanks
Royalty pharma to buy its external manager, announces $3B share buyback - MSN
Royalty Pharma stock price target raised to $38 from $37 at UBS - Investing.com Nigeria
Gainers Report: Will Royalty Pharma plc outperform the market in YEARMarket Sentiment Summary & Stock Timing and Entry Methods - خودرو بانک
Street Watch: Does Santech Holdings Limited Depositary Receipt offer margin of safetyGlobal Markets & Fast Gain Swing Trade Alerts - khodrobank.com
Royalty Pharma (RPRX) PT Raised to $38 at UBS, But Firm on Sidelines Due to Structural Issues - StreetInsider
Royalty Pharma plc (RPRX) Reports 20% Portfolio Growth, Posts $727M in Q2 Receipts - Yahoo Finance
Royalty Pharma Plc's (NASDAQ:RPRX) Prospects Need A Boost To Lift Shares - 富途牛牛
Aug Chart Watch: Is Royalty Pharma plc stock technically oversoldTrade Risk Assessment & Community Verified Trade Alerts - خودرو بانک
Petrus Trust Company LTA Takes Position in Royalty Pharma PLC $RPRX - MarketBeat
12 Cheap Healthcare Stocks to Buy Now - Insider Monkey
Q2 Earnings Roundup: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Segment - Yahoo Finance
Signal Recap: Will Royalty Pharma plc be affected by tariffs2025 Earnings Surprises & AI Powered Market Entry Strategies - خودرو بانک
USS Investment Management Ltd Sells 42,500 Shares of Royalty Pharma PLC $RPRX - MarketBeat
EP Wealth Advisors LLC Takes Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (RPRX): Evaluating Valuation After $2 Billion Debt Offering and New Capital Moves - Sahm
Uniplan Investment Counsel Inc. Purchases 11,904 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Stake Lessened by Baird Financial Group Inc. - MarketBeat
Finanzdaten der Royalty Pharma Plc-Aktie (RPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):